Trending Tickers: Lululemon Athletica inc. (NASDAQ:LULU), Geron Corporation (NASDAQ:GERN), Keurig Green Mountain Inc (NASDAQ:GMCR), Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN), Mobile Iron Inc (NASDAQ:MOBL)

Lululemon Athletica inc. (NASDAQ:LULU) announced that Chief Financial Officer John Currie has notified the company of his intent to retire by the end of the fiscal year. Lululemon Athletica inc. (NASDAQ:LULU) will engage a leading executive search firm to initiate an open and comprehensive search for Mr. Currie’s replacement to allow for a smooth transition. Lululemon Athletica inc. (NASDAQ:LULU) net profit margin is 20.50% and weekly performance is -13.11%. On last trading day company shares ended up $37.25. Analysts mean target price for the company is $56.86. Lululemon Athletica inc. (NASDAQ:LULU) distance from 50-day simple moving average (SMA50) is -20.96%.

Geron Corporation (NASDAQ:GERN) said that company is currently developing its imetelstat drug for a form of Leukemia commonly known as Myelofibrosis. Geron Corporation (NASDAQ:GERN) shares advanced 21.15% in last trading session and ended the day on $3.15. GERN return on assets is -38.30%. Geron Corporation (NASDAQ:GERN) quarterly performance is 75.98%.

Keurig Green Mountain Inc (NASDAQ:GMCR) announced that it is partnering with sandwich chain Subway to serve its single-serve brews across the restaurant’s North American locations. Keurig Green Mountain Inc (NASDAQ:GMCR) ‘s president of U.S. sales and marketing, John Whoriskey, said in a statement: “Keurig’ brewers help SUBWAY franchisees simplify operations by eliminating the need for separate brewing of regular, decaffeinated and flavored coffee, reducing waste and clean-up of unconsumed coffee. Keurig Green Mountain Inc (NASDAQ:GMCR) shares moved up 4.11% in last trading session and was closed at $120.75, while trading in range of $115.11 – $123.60. Keurig Green Mountain Inc (NASDAQ:GMCR) year to date (YTD) performance is 60.72%.

Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) reported ($0.17) EPS for the quarter, missing the Thomson Reuters consensus estimate of ($0.16) by $0.01. Analysts expect that Achillion Pharmaceuticals will post $-0.77 EPS for the current fiscal year. Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) ended the last trading day at $6.83. Company weekly volatility is calculated as 17.91% and price to cash ratio as 4.71. Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) showed a positive weekly performance of 140.49%.

Mobile Iron Inc (NASDAQ:MOBL) announced that it priced its initial public offering of 11.11 million shares of its common stock at a price of $9.00 per share. Mobile Iron Inc (NASDAQ:MOBL) on last trading day company shares ended up $11.02.

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *